This compound is primarily utilized in the pharmaceutical industry as an active pharmaceutical ingredient (API) in the development of medications targeting inflammatory and autoimmune diseases. Its unique structure allows it to modulate specific biological pathways, making it effective in reducing inflammation and regulating immune responses. It is often incorporated into formulations for treating conditions such as psoriasis, rheumatoid arthritis, and other chronic inflammatory disorders. The addition of N-acetyl-L-leucine enhances its stability and bioavailability, ensuring better therapeutic outcomes. Research is also ongoing to explore its potential in other therapeutic areas, including neurodegenerative diseases and cancer, due to its ability to influence cellular signaling mechanisms.